Human Interleukin Genes Research References – Term Paper

Reference

Van den Biggelaar, A. H., van Ree, R., Rodrigues, L. C., Lell, B., Deelder, A. M., Kremsner, P.        G., & Yazdanbakhsh, M. (2000). Decreased atopy in children infected with Schistosoma      haematobium: a role for parasite-induced interleukin-10. The Lancet, 356(9243), 1723-           1727. Website <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141221/>

Kouriba, B., Chevillard, C., Bream, J. H., Argiro, L., Dessein, H., Arnaud, V. & Traore,         H.A.    (2005). Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL- 13-591A/G polymorphisms and Schistosoma haematobium    infections.The  Journal of       Immunology, 174(10), 6274-6281.Steinmann P, Keiser        J, Bos R, Tanner M, Utzinger  J. Schistosomiasis and water resources development: systematic review, meta-analysis,          and estimates of people at risk.Lancet Infect Dis. 2006;6:411425.

Howard, T. D., Whittaker, P. A., Zaiman, A. L., Koppelman, G. H., Xu, J., Hanley, M. T., … &         Bleecker, E. R. (2001). Identification and association of polymorphisms       in the  interleukin-13 gene with asthma and atopy in a Dutch population. American Journal of         Respiratory Cell and Molecular Biology, 25(3), 377-384.Terefe       Ashenafi,Shimelis        Techalew, Mengistu Mulugeta, Hailu Asrat, Erko Berhanu. Schistosomiasis mansoni and     soil-transmitted helminthiasis in Bushulo village, southern Ethiopia. Ethiop J Health Dev.       2011;25(1):4650.

Marquet, S., Abel, L., Hillaire, D., & Dessein, A. (1999). Full results of the genome-wide scan             which localises a locus controlling the intensity of infection by Schistosoma mansoni on  chromosome 5q31q33. European Journal of Human            Genetics, 7(1).Alemu Abebe,   Atnafu Asmamaw, Addis Zelalem, et al. Soil transmitted helminths and    Schistosoma    mansoni infections among school children in Zarima town,     northwest            Ethiopia.         BMC Infect Dis. 2011;11:189.

Gyan, B. A., Goka, B., Cvetkovic, J. T., Kurtzhals, J. L., Adabayeri, V., Perlmann, H. &       TROYEBLOMBERG, M. (2004). Allelic polymorphisms in the repeat and  promoter regions of the interleukin4 gene and malaria severity in Ghanaian    children. Clinical & Experimental Immunology, 138(1), 145-150.

Casanova, J. L., & Abel, L. (2007). Human genetics of infectious diseases: a unified theory    . EMBO journal, 26(4), 915-922.

Cooke, G. S., & Hill, A. V. (2001). Genetics of susceptibitlity to human infectious      disease. Nature Reviews Genetics, 2(12), 967-977.

Casanova, J. L., & Abel, L. (2007). Human genetics of infectious diseases: a unified   theory. The EMBO journal, 26(4), 915-922.

He, H., Isnard, A., Kouriba, B., Cabantous, S., Dessein, A., Doumbo, O., & Chevillard, C.     (2008). A STAT6 gene polymorphism is associated with high infection levels in urinary        schistosomiasis. Genes and immunity, 9(3), 195-206.

Kato, S., Onda, M., Yamada, S., Matsuda, N., Tokunaga, A., & Matsukura, N. (2001).           Association of the interleukin-1 b genetic polymorphism and gastric cancer risk in    Japanese. Journal of gastroenterology, 36(10), 696-699.

Hill, A. V. (2001). The genomics and genetics of human infectious disease susceptibility        .          Annual review of genomics and human genetics, 2(1), 373-400.

Dessein, A. J., Hillaire, D., Elwali, N. E. M., Marquet, S., Mohamed-Ali, Q., Mirghani, A., … &         Abel, L. (1999). Severe hepatic fibrosis in Schistosoma mansoni  infection is controlled  by a major locus that is closely linked to the interferon-g          receptor gene. The American   Journal of Human Genetics, 65(3), 709-721.

Mege, J. L., Meghari, S., Honstettre, A., Capo, C., & Raoult, D. (2006). The two faces of       interleukin 10 in human infectious diseases. The Lancet infectious diseases, 6(9),          557-    569.

Lu, W., Pan, K., Zhang, L., Lin, D., Miao, X., & You, W. (2005). Genetic     polymorphisms of       interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor a and risk of gastric       cancer in a Chinese population. Carcinogenesis, 26(3),           631-636.

Hill, A. V. (1998). The immunogenetics of human infectious diseases. Annual review of         immunology, 16(1), 593-617.

Henri, S., Chevillard, C., Mergani, A., Paris, P., Gaudart, J., Camilla, C., … & Magzoub         ,M.      (2002). Cytokine regulation of periportal fibrosis in humans infected with  Schistosoma    mansoni: IFN-g is associated with protection against fibrosis and          TNF-a with     aggravation of disease. The Journal of Immunology, 169(2), 929-936.

Hanifin JM. Atopic dermatitis. J Am Acad Dermatol1982;6:113.

Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol1999;104:S99 S108.

Kagi MK, Wuthrich B, Montano E, Barandun J, Blaser K, Walker C. Differential        cytokine          profiles in peripheral blood supernatants and skin biopsies from patients  with different   forms of atopic dermatitis, psoriasis and normal individuals. Int            Arch Allergy Immunol 1994;103:332340.

Reinhold U. T cell mediated immunoregulation in atopic dermatitis. In: WuthrichB, editor.    Highlights in allergy and clinical immunology. Seattle, WA: Hogrefe and    Huber, 1992:3.

Akdis M, Akdis CA, Weigl L, Disch R, Blaser K. Skin-homing, CLA⁺ memory T cells are      activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern.    IgG4 counter-regulation by CLA- memory T cells. J Immunol1997;59:46114619.

Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute  versus chronic atopic dermatitis. J Clin Invest1994;94:870876.

Fujimura T, Yamanashi R, Masuzava M, Fujita Y, Katsuoka K, Nishiyama Set al.Conversion of the CD4⁺ T cell profile from Th2-dominant type to Th1-dominant        type after         varicella-zoster virus infection in atopic dermatitis. J Allergy Clin         Immunol          1997;100:274282.

Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M. Predominance of         type 2 cytokine-producing CD4⁺ and CD8⁺ cells in patients with atopic dermatitis. J Allergy           Clin Immunol1997;99:673682.

Walker C, Kagi MK, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen CAFMet al.Atopic      dermatitis. correlation of peripheral blood T cell activation, eosinophilia    and serum                    factors with clinical severity. Clin Exp Allergy1993;23:145153.

Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DYM. In vivo   expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol          1996;98:225231.

Bratton D, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. Granulocyte     macrophage colony-stimulating factor contributes to enhanced        monocyte survival in   chronic atopic dermatitis. J Clin Invest1995;95:211218.

Website <http://www.jimmunol.org/content/174/10/6274.short>

Website <http://www.hindawi.com/journals/mi/2013/434010/>

M. M. Wong and E. N. Fish, Chemokines: attractive mediators of the immune          response,       Seminars in Immunology, vol. 15, no. 1, pp. 514, 2003.

D. Raman, T. Sobolik-Delmaire, and A. Richmond, Chemokines in health and disease,      Experimental Cell Research, vol. 317, no. 5, pp. 575589, 2011.

C. Hartel, N. Adam, T. Strunk, P. Temming, M. Muller-Steinhardt, and C. Schultz,     Cytokine responses correlate differentially with age in infancy and early    childhood,Clinical and Experimental Immunology, vol. 142, no. 3, pp. 446453,     2005.

M. Benahmed, B. Meresse, B. Arnulf et al., Inhibition of TGF-b signaling by IL-15: a           new     role for IL-15 in the loss of immune homeostasis in celiac disease, Gastroenterology,                    vol. 132, no. 3, pp. 9941008, 2007.

S. A. Y. Hartgring, J. W. J. Bijlsma, F. P. J. G. Lafeber, and J. A. G. Van Roon, Interleukin-7            induced immunopathology in arthritis, Annals of the Rheumatic       Diseases, vol. 65,        supplement 3, pp. iii69iii74, 2006.

A. Alam, C. Pal, M. Goyal, et al., Synthesis and bio-evaluation of human macrophage migration      inhibitory factor inhibitor to develop anti-inflammatory agent, Bioorganic &    Medicinal Chemistry, vol. 19, no. 24, pp. 73657373, 2011.

J. Braun, X. Baraliakos, J. Brandt et al., Persistent clinical response to the anti-TNF-a antibody infliximab in patients with ankylosing spondylitis over 3 years, Rheumatology, vol. 44, no. 5, pp. 670676, 2005.

P. Rutgeerts, W. J. Sandborn, B. G. Feagan et al., Infliximab for induction and          maintenance    therapy for ulcerative colitis, New England Journal of Medicine,    vol. 353, no. 23, pp.   24622476, 2005.

N. Woolacott, Y. Bravo Vergel, N. Hawkins et al., Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation,    Health Technology Assessment, vol. 10, no. 31, pp. 1239, 2006.

G. M. Keating and C. M. Perry, Infliximab: an updated review of its use in Crohn’s disease and ;;;;;;;;rheumatoid arthritis,;BioDrugs, vol. 16, no. 2, pp. 111148, 2002.

Chabasse D, Bertrand G, Leroux JP, Gauthey N. Hocquet P. Developmental bilharziasis ;;;;;;;;caused by;Schistosoma mansoni;discovered 37 years after infestation. Bull Soc ;;;Pathol Exot;;;;;;;;;;;;;;;;; Filiales. 1985;78:643647.

Verani JR, Abudho B, Montgomery SP, et al. Schistosomiasis among young children in ;;;;;;;;Usoma, Kenya. Am J Trop Med Hyg. 2011;84:787791.

Warren KS, Mahmoud AA, Cummings P, Murphy DJ. Houser HB. Schistosomiasis ;;;mansoni in Yemeni in California: duration of infection, presence of disease, ;;;;;;;;;;therapeutic management. Am J Trop Med Hyg. 1974;23:902909.

Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Closing the praziquantel treatment gap: ;;;new steps in epidemiological monitoring and control of schistosomiasis in ;;;;;;;African ;;;;;;;;;;;infants and preschool-aged children. Parasitology. 2011;138:15931606.

;Website ;http://internationalscholarsjournals.org/viewhtml.php?id=509e9bee05444;

;Website ;http://iai.asm.org/content/77/5/2051.short;

Mwatha, J. K., Kimani, G., Kamau, T., Mbugua, G. G., Ouma, J. H., Mumo, J., … ; Dunne, D. ;;;;;;;W. (1998). High levels of TNF, soluble TNF receptors, soluble ;;;;;;;;ICAM-1, and IFN-g, ;;;but low levels of IL-5, are associated with hepatosplenic ;;;;;;;;;disease in human ;;;;;;;;schistosomiasis mansoni.;The Journal of Immunology,;160(4), 1992-1999.

Silveira, A. M., Gazzinelli, G., Alves-Oliveira, L. F., Bethony, J., Gazzinelli, A., Carvalho-;;;;;Queiroz, C., … ; Correa-Oliveira, R. (2004). Human schistosomiasis mansoni: intensity ;;;;;;of infection differentially affects the production of interleukin-;;10, interferon-g and ;;;;interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. ;;;;;;Transactions of the Royal Society of Tropical Medicine and ;;;Hygiene,;98(9), 514-;;;519.

Fumagalli, M., Pozzoli, U., Cagliani, R., Comi, G. P., Riva, S., Clerici, M., … ; Sironi, ;;;;;;;;M. ;;;;;;(2009). Parasites represent a major selective force for interleukin genes and shape the ;;;;;;;;;;genetic predisposition to autoimmune conditions.;The Journal of ;;;;;;;experimental ;;medicine,206(6), 1395-1408.

Henri, S., Chevillard, C., Mergani, A., Paris, P., Gaudart, J., Camilla, C., … ; Magzoub, ;;;;;;;M. ;;;;;;(2002). Cytokine regulation of periportal fibrosis in humans infected with ;Schistosoma ;;;mansoni: IFN-g is associated with protection against fibrosis and TNF-a with aggravation ;;;;;;;of disease.;The Journal of Immunology,;169(2), 929-936.

Dessein, A., Kouriba, B., Eboumbou, C., Dessein, H., Argiro, L., Marquet, S., ;;;;;;;;;Chevillard, C. (2004). Interleukin13 in the skin and interferong in the liver are ;;;;key players in ;immune protection in human schistosomiasis.;Immunological reviews,;201(1), 180-190.